Newsroom | 24904 results

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today published its 2025 Sustainability Report. The report highlights IQVIA’s progress across its People, Public and Planet pillars, consistent with the company’s mission to accelerate innovation for a healthier world. IQVIA’s 2025 Sustainability Report can be downl...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers announced today that it will participate in TD Cowen’s 46th Annual Health Care Conference, taking place March 2-4, 202...

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--CFG Health today announced the launch of CFG CareLink™, a proprietary, in-house telehealth platform that represents the next evolution of the company’s long-standing leadership in technology-enabled correctional healthcare. CFG Health pioneered the use of telehealth in correctional settings more than two decades ago, and CareLink builds on that foundation—combining modern tablet technology, secure virtual care infrastructure, and clinically governed workflow...

MANHASSET, N.Y.--(BUSINESS WIRE)--In recognition of their impact on society through the successful production, patenting and commercialization of groundbreaking technologies, four esteemed scientists from Northwell Health’s Feinstein Institutes for Medical Research – Lior Brimberg, PhD; Jared M. Huston, MD; Stavros Zanos, MD, PhD; and Theodoros Zanos, PhD – have been named to the prestigious 2026 class of Senior Members by the National Academy of Inventors (NAI). This significant recognition hi...

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in digital validation lifecycle management, will exhibit its Smart GxP™ platform at the ISPE Europe Annual Conference, April 20-22, in Copenhagen, Denmark. As pharmaceutical and biotechnology manufacturers navigate increasing regulatory expectations, operational complexity, and the integration of artificial intelligence into GxP environments, ValGenesis product specialists will be on-site to connect with pharmaceutical eng...

NEW ORLEANS--(BUSINESS WIRE)--Medsynaptic, a global provider of enterprise imaging and PACS solutions, today announced its participation in the AAOS Annual Meeting....

SAMARATE, Italy--(BUSINESS WIRE)--Quanta System Sp.A., a leading company in laser technologies for surgery, dermatology, and aesthetic medicine, 100% Made in Italy and part of the El.En. Group, announced today the establishment of Quanta System Inc., a new US entity based in North Carolina, officially operational as of March 1, 2026. The creation of a direct presence in the US Surgical and Urology market, represents a strategic step in the international expansion of the organization. By launchi...

SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a patient-centric solution for urgency urinary incontinence (UUI), today announced that three-year results from the pivotal OASIS study were presented by Roger Dmochowski, M.D., Chief Medical Officer, BlueWind Medical, at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) 2026 Winter Meeting. The data confirm Rev...

EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Results: Revenue of $83.3 million, growing 9% year-over-year GAAP loss of $23.4 million, or ($0.76) per share Non-GAAP income of $5.2 million, or $0.16 per sha...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated February 2, 2026, it has surpassed the Minimum Subscription and closed on an Initial Closing of $2,700,000 of the non-brokered Private Placement to accredited investors. The Private Placement is for up to $5,000,000 by issuance of up to 100 Convertible Loan Notes, each with a face value of $50,000 (“Series IV Notes”). The Series IV Notes...